Betadex Sulfobutyl Ether Sodium SBECD Pharmaceutical Grade Cyclodextrin for Injectable Formulations

Betadex Sulfobutyl Ether Sodium SBECD Pharmaceutical Grade Cyclodextrin for Injectable Formulations

CAS Number: 182410-00-0

Appearance: White to off-white powder

Molecular Formula: C42H70O35

Molecular Weight: 1310.29

Grade: Pharmaceutical Grade

Application: Injectable and parenteral formulations; pharmaceutical excipient for solubility and stability enhancement

Product Description

Betadex Sulfobutyl Ether Sodium SBECD is a high-purity, pharmaceutical-grade cyclodextrin derivative. Betadex Sulfobutyl Ether Sodium SBECD functions as a solubilizer and stabilizer for poorly soluble active pharmaceutical ingredients, improving solubility, formulation stability, and bioavailability.

Betadex Sulfobutyl Ether Sodium SBECD demonstrates excellent safety and biocompatibility. Betadex Sulfobutyl Ether Sodium SBECD forms strong inclusion complexes with various drug molecules and is suitable for injectable, oral, and ophthalmic drug formulations, supporting enhanced drug performance and reduced irritation at the administration site.

Each batch of Betadex Sulfobutyl Ether Sodium SBECD is tested to ensure high assay purity, low endotoxin levels, and minimal residual solvents and heavy metals. Betadex Sulfobutyl Ether Sodium SBECD complies with USP and EP pharmacopeial specifications, guaranteeing consistent quality for pharmaceutical applications worldwide.

Commercial-scale and pilot-scale quantities of Betadex Sulfobutyl Ether Sodium SBECD are available with full regulatory support, including Certificate of Analysis (COA), Material Safety Data Sheet (MSDS), stability data, and technical dossiers. Custom packaging options and sample requests are available.

Product Applications

• Injectable and intravenous formulations
• Ophthalmic solutions
• Oral liquid formulations
• Parenteral nutrition formulations
• Antiviral, antifungal, anticancer, and cardiovascular drug development
• Protein stabilization and solubility enhancement
• Controlled release formulations

Already Marketed Products Using SBECD

• Antiviral drug formulations for hospital use
• Injectable antifungal agents
• Oncology injectable solutions
• Cardiovascular injectables for critical care
• Ophthalmic formulations for improved bioavailability

Company Introduction – Xi’an Deli Biochemical Industry Co., Ltd.

Established in 1999, Xi’an Deli Biochemical Industry Co., Ltd. is a high-tech enterprise specializing in research, development, production, and sales of cyclodextrin derivatives. With over 26 years of experience, Xi’an Deli Biochemical operates dedicated production lines and clean areas designed for pharmaceutical excipients, providing stable quality and long-term supply to global pharmaceutical customers.

The company currently produces Hydroxypropyl Betadex (HPBCD) and Betadex Sulfobutyl Ether Sodium (SBECD), registered with FDA, and its quality management system has passed ISO 9001:2015 certification.

Product Specifications

• Pharmaceutical grade, USP–NF and EP compliant
• Assay ≥ 99.0%
• High water solubility and biocompatibility
• CAS No. 182410-00-0
• HS Code: 35051000.00
• Application: Injectable and parenteral formulations
• Packaging: 500 g/bag; 10 kg/drum or customized
• Free sample (100 g) available
• Global shipping available

COA (Certificate of Analysis)

FAQ

Q1: Is Xi’an Deli Biochemical the manufacturer of Betadex Sulfobutyl Ether Sodium?
A1: Xi’an Deli Biochemical produces cyclodextrin derivatives such as HPBCD and SBECD. Beta Cyclodextrin is used as the raw material for derivative production, not manufactured by Xi’an Deli Biochemical itself.

Q2: What is the lead time for Betadex Sulfobutyl Ether Sodium?
A2: Delivery is typically 5–7 working days for trial orders; bulk orders depend on order quantity.

Q3: What are the available quantities for trial and commercial supply?
A3: Free sample of 100 g is available. Commercial orders can be supplied in 500 g, 1 kg, 10 kg packaging, or customized amounts.

Q4: Does Betadex Sulfobutyl Ether Sodium meet pharmacopeial standards?
A4: Yes, Betadex Sulfobutyl Ether Sodium complies with USP and EP specifications.

Q5: Can you provide COA and regulatory documents?
A5: Yes, COA, MSDS, and stability data are available upon request.